Cadrenal Therapeutics
CVKD
#11070
Rank
ยฃ3.54 M
Marketcap
ยฃ1.14
Share price
0.00%
Change (1 day)
-87.13%
Change (1 year)

EPS for Cadrenal Therapeutics (CVKD)

EPS in 2026 (TTM): -ยฃ3.98

According to Cadrenal Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ4.06. In 2025 the company made an earnings per share (EPS) of -ยฃ5.03 an increase over its 2024 EPS that were of -ยฃ6.61.

EPS history for Cadrenal Therapeutics from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ3.98-20.84%
2025-ยฃ5.03-23.94%
2024-ยฃ6.61-6.03%
2023-ยฃ7.04